Oral Cavity Carcinoma
Information
- Disease name
- Oral Cavity Carcinoma
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02834013 | Active, not recruiting | Phase 2 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | January 30, 2017 | May 1, 2026 |
| NCT00867464 | Active, not recruiting | Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls | March 30, 2009 | December 31, 2023 | |
| NCT02581137 | Active, not recruiting | Phase 2 | Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion | June 10, 2016 | December 22, 2024 |
| NCT02882282 | Active, not recruiting | Phase 2 | Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia | June 14, 2017 | December 31, 2024 |
| NCT00780312 | Completed | Phase 2 | Physiotherapy Treatment for Patients Suffering From Head and Neck Cancer | December 2008 | March 2012 |
| NCT03488095 | Completed | N/A | Behavior Changing Intervention for Smokeless Tobacco and Betel Quid Use in Adolescents | May 1, 2016 | December 30, 2018 |
| NCT04788264 | Completed | N/A | Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer Treatment | March 28, 2021 | June 29, 2023 |
| NCT05973656 | Recruiting | N/A | Role of Acetaldehyde in the Development of Oral Cancer | July 8, 2022 | September 30, 2027 |
| NCT04870762 | Recruiting | Phase 2 | Customized 3D Printed Oral Stents During Head and Neck Radiotherapy | May 26, 2021 | November 6, 2024 |
| NCT05075980 | Recruiting | Phase 2 | HEADLIGHT: Hypofractionated Proton Therapy for Head and Neck Cancers | February 16, 2022 | November 15, 2026 |
| NCT04162873 | Suspended | Phase 2 | Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer | November 27, 2019 | October 12, 2025 |
| NCT05536037 | Terminated | Phase 1 | Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions | May 4, 2022 | March 16, 2024 |